These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1932067)
21. Efficacy of Liposomal Monensin on the Enhancement of the Antitumour Activity of Liposomal Ricin in Human Epidermoid Carcinoma (KB) Cells. Tyagi N; Rathore SS; Ghosh PC Indian J Pharm Sci; 2013 Jan; 75(1):16-22. PubMed ID: 23901156 [TBL] [Abstract][Full Text] [Related]
22. Induction of ligand carrying "natural liposomes" in cancer cells. Timár J; Bradley N; Robertson D; Davies AJ Acta Morphol Hung; 1986; 34(4):299-310. PubMed ID: 3118647 [TBL] [Abstract][Full Text] [Related]
23. The lower cytotoxicity of cinnamomin (a type II RIP) is due to its B-chain. Wang BZ; Zou WG; Liu WY; Liu XY Arch Biochem Biophys; 2006 Jul; 451(1):91-6. PubMed ID: 16762311 [TBL] [Abstract][Full Text] [Related]
24. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection. Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938 [TBL] [Abstract][Full Text] [Related]
27. Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b]quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells. Jaromin A; Kozubek A; Suchoszek-Lukaniuk K; Malicka-Blaszkiewicz M; Peczynska-Czoch W; Kaczmarek L Drug Deliv; 2008 Jan; 15(1):49-56. PubMed ID: 18197524 [TBL] [Abstract][Full Text] [Related]
28. Insulin-ricin B chain conjugate. A hybrid molecule with ricin-binding activity and insulin biological activity. Roth RA; Maddux BA; Wong KY; Iwamoto Y; Goldfine ID J Biol Chem; 1981 Jun; 256(11):5350-4. PubMed ID: 7016852 [TBL] [Abstract][Full Text] [Related]
29. In vivo potentiation of ricin toxicity by monensin delivered through liposomes. Vasandani VM; Madan S; Ghosh PC Biochim Biophys Acta; 1992 Jun; 1116(3):315-23. PubMed ID: 1377030 [TBL] [Abstract][Full Text] [Related]
30. Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances. Tyagi N; Tyagi M; Pachauri M; Ghosh PC Tumour Biol; 2015 Nov; 36(11):8239-46. PubMed ID: 26349746 [TBL] [Abstract][Full Text] [Related]
31. Interferon sensitive and insensitive MHC variants of a murine thymoma differentially resistant to methotrexate-containing antibody-directed liposomes and immunotoxin. Machy P; Arnold B; Aliño S; Leserman LD J Immunol; 1986 Apr; 136(8):3110-5. PubMed ID: 2420883 [TBL] [Abstract][Full Text] [Related]
32. Influence of the galactosyl ligand structure on the interaction of galactosylated liposomes with mouse peritoneal macrophages. Haensler J; Schuber F Glycoconj J; 1991 Apr; 8(2):116-24. PubMed ID: 1823615 [TBL] [Abstract][Full Text] [Related]
33. Uptake of antibody directed cytotoxic liposomes by CD3 on human T cells. Gray AG; Morgan J; Linch DC; Huehns ER Clin Exp Immunol; 1988 Apr; 72(1):168-73. PubMed ID: 3260836 [TBL] [Abstract][Full Text] [Related]
34. Treatment of ricin A-chain-induced hepatotoxicity with liposome-encapsulated N-acetylcysteine. Buonocore C; Alipour M; Omri A; Pucaj K; Smith MG; Suntres ZE J Drug Target; 2011 Nov; 19(9):821-9. PubMed ID: 21615215 [TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of streptavidin-blocked biotinyl-ricin is retrieved by in vitro immunotargeting via biotinyl monoclonal antibody. Schechter B; Arnon R; Wilchek M Cancer Res; 1992 Aug; 52(16):4448-52. PubMed ID: 1643636 [TBL] [Abstract][Full Text] [Related]
36. Preparation, Characteristics and Toxicity of Ricin-containing Galactosyl Ceramide Liposomes. Zhang J; Qin DA; Cheng BX; Ru XQ; Li H; Li L; Yang HP Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1999; 31(4):472-474. PubMed ID: 12115009 [TBL] [Abstract][Full Text] [Related]
37. Putrescine-stimulated intracellular Ca2+ release for invasiveness of rat ascites hepatoma cells. Ashida Y; Ueno A; Miwa Y; Miyoshi K; Inoue H Jpn J Cancer Res; 1998 Jan; 89(1):67-75. PubMed ID: 9510478 [TBL] [Abstract][Full Text] [Related]
38. Renaturated ricin toxin B chain made in Escherichia coli is soluble, stable, and biologically active. Tonevitsky A; Toptygin A; Agapov I; Pfueller U; Frankel A Biochem Mol Biol Int; 1994 Apr; 32(6):1139-46. PubMed ID: 8061631 [TBL] [Abstract][Full Text] [Related]
39. Effect of ricin or ricin A-chain encapsulated in anti-carcinoembryonic antigen (CEA) antibody-bearing liposomes on CEA-producing tumor cells. Watanabe Y; Osawa T Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):740-7. PubMed ID: 3594685 [No Abstract] [Full Text] [Related]
40. Anticancer Activities of Ricin-Liposome Complexes on SKMEL-28 Cells. Bich Loan NT; Trung NN; Le Na NT; Thang ND Asian Pac J Cancer Prev; 2019 Jul; 20(7):2117-2123. PubMed ID: 31350974 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]